跳至主要内容
临床试验/NCT06453083
NCT06453083已完成早期 1 期

Prospective Randomized Trial Using Medrol Dose Packs for Post-Operative Pain Control

University of Utah1 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2023年1月13日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
入组人数
57
试验地点
1
主要终点
Visual Analog Scale (VAS) pain

研究概览

简要总结

The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.

详细描述

Post-operative pain control following AIS surgery is challenging. Sub-optimal pain management results in emotional distress and prolonged hospital length of stay. Previous studies have shown that a short course of steroids following spine surgery is safe and improves pain control. To better understand the effects of the addition of steroids to a routine pain management strategy, a randomized prospective study with and without steroids will determine the benefit, if any, to the addition of steroids to the investigators already used pain protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
10 Years 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • age range of 10-21
  • received AIS surgery

排除标准

  • participants out of the age range 10-21
  • other forms of scoliosis (not AIS)

研究组 & 干预措施

Placebo tablets

Placebo Comparator

Encapsulated placebo tablets per day (dosage for day 1 following the surgery is 32mg, day 2 is 24mg, day 3 is 16mg, day 4 is 12mg, day 5 is 8mg and day 6 is 4mg.)

干预措施: Placebo (Drug)

Medrol tablets

Experimental

Encapsulated steroid Medrol tablets (dosage for day 1 following the surgery is 32mg, day 2 is 24mg, day 3 is 16mg, day 4 is 12mg, day 5 is 8mg and day 6 is 4mg)

干预措施: Medrol (Drug)

结局指标

主要结局

Visual Analog Scale (VAS) pain

时间窗: Day 6, post (AIS) surgery

VAS pain score (0 no pain - 10 severe pain)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joshua Klatt

Principle Investigator

University of Utah

研究点 (1)

Loading locations...

相似试验